As of 4:00pm ET
| -0.54 / -1.75%|
The 6 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 36.50, with a high estimate of 53.00 and a low estimate of 19.00. The median estimate represents a +20.54% increase from the last price of 30.28.
The current consensus among 7 polled investment analysts is to Buy stock in Arena Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.